Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome

Bone Marrow Transplant. 2009 May;43(9):739-40. doi: 10.1038/bmt.2008.381. Epub 2008 Dec 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab
  • Combined Modality Therapy / methods
  • Humans
  • Male
  • Middle Aged
  • POEMS Syndrome / therapy*
  • Peripheral Blood Stem Cell Transplantation / methods*
  • Thalidomide / administration & dosage*
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Thalidomide